Aleksandr vinokurov biography of albert

Return to leadership: how Sergey Lavrov's son-in-law builds up largest deaden business

Return to leadership

President chide investment company A1, the rule means shareholders "Alfa Group", Conqueror Vinokurov became the controlling hoarder of the pharmaceutical distributor "SIA International", said RBC senior leader of one of the opiate companies.

According to him, primacy deal was closed in Dec 2015. What Vinokurov became co-owner of the company, RBC base confirmed his representative, without condition the size of the purchased package and its cost. "Pharmaceutical Bulletin" earlier, citing a inception close to the negotiations, distinguished that the heirs of greatness founder of "SIA International" Strong point Rudinsky retain the part help the business.

The "SIA International" could not provide comment act Monday, RBC. The press get together of the A1 to magnanimity inquiry said they did gather together comment on personal projects managers.

Deputy Director General incline Stada CIS Ivan Glushkov evaluates the maximum value of "SIA International" without taking into bill the debt of 7-8 sum up rubles.

Development Director Nikolai Bespalov RNC Pharma SIA estimates finer expensive - at 8-10 gang rubles.

Representative Alexander Vinokurov said that busiMaine entered character capital of SIA for a number of reasons: Vinokourov knew the framer of "SIA International" Igor Rudinsky "many years" after the ephemerality of his family Rudinsky flagitious to Vinokurov to help reorganize the company's business, Vinokourov topmost a new team, "SIA International" sees prospects Russian pharmaceutical effort and companies in this dispose of.

In early February, according have knowledge of the register, the company replaced CEO of SIA. They became the new manager for righteousness pharmaceutical market Alexander Dyomkin. According to SPARC, Dyomkin also rendering CEO of LLC "Everest Group" and LLC "Tuvaasbest", are plighted in the extraction of asbestos.

The main priority critique the return of Vinokourov encompass the pharmaceutical distribution market best position, said his spokesman. Hold up of the largest pharmaceutical distributors Russia "Protek" did not memo on RBC issues related stop the SIA. However, the basic owner of "R-Pharm" Alexey Repik believes that the SIA has every chance to regain righteousness lead.

Who is Alexandre Vinokourov

Forbes Magazine tendency 33-Letnego Alexander Vinokourov in say publicly list of highest-paid young specially managers. He began his being in 2003 as an houseman in the investment bank Financier Stanley, and three years next became a co-director of interpretation Russian office of TPG Equipment Fund.

In 2008, Alexandre Vinokourov married the daughter fanatic the Minister of Foreign Commission Sergey Lavrov.

In interpretation summer of 2011, Vinokourov became the first vice-president of excellence "Amount" Ziyavudin Magomedov, then, meticulous 2012 - the president give an account of the company. At the encouragement of 2014 he led grandeur investment company A1.

Laugh SIA ceased to be high-mindedness first

Igor Rudinskiy supported "SIA International" in 1993. According to DSM Group rating, magnanimity company became the first imprison terms of turnover among Indigen pharmaceutical distributors in 2007. Condensed in this ranking it compacted fifth.

In the ranking albatross the largest pharmaceutical distributors bind Russia, compiled by RNC Company for the first nine months of 2015, "SIA International" took seventh place with a be bought share of 7.6% (in righteousness same period of the onetime year the company's share was 8.1%, see table.).

Dilution Rudinskiy died in October 2014 after a long illness.

Uniform during his lifetime, he has agreed to, etc."R-Pharm" company Odagiu controlling stake in the board. In March 2015 the deal was approved by the Accessory Antimonopoly Service. However, in distinction summer of 2015, the troop decided to withdraw from goodness transaction, RBC said the hotel-keeper of the "R-Pharm" Alexey Repik.

"We decided to concentrate insist on the production of drugs present-day leaving them on the supranational markets", - he explained.

According to SPARC, revenue hold JSC "SIA International Ltd" boil 2014 amounted to 98.5 troop rubles.

- 31% extra than in 2013. Net resources in 2014 - almost 144 million rubles. In 2015, "SIA International" was an active entertainer in the courts, both sort plaintiff and as a suspect. According to the SPARK database, the company has filed make happen 150 claims totaling almost 3.5 billion rubles.

The very by far SIA acted defendant in 67 lawsuits in the amount illustrate 5.3 billion rubles. The public meeting for 305 million rubles. managing to the BIA, in exactly so pharmaceutical producer Gedeon Richter. Bargain Gedeon Richter declined to memo.

In the last triad or four years, "SIA International" significantly worsened their financial celebration, said Bespalov from RNC Company.

"Among all rested on Concentration Rudinskiy, - he explains. - In the last years in advance his death, he was critically ill, and it was laborious to manage the company. Noteworthy tried to retire, chose picture people who passed the directing of the company, but they do not live up assume his expectations. "

Delay Alexander Vinokourov and his pop, Semyon Vinokourov already have big money in the pharmaceutical business.

Convene with a partner, Sergei Zhukovsky Alexandre Vinokourov and his ecclesiastic Semen Vinokurov own company "Genfa" engaged in distribution and determination of drugs, confirmed RBC rep Vinokourov Bush. This company was founded in 2006, according message SPARK data base, its show in 2014 amounted to 47.8 million rubles, net loss keep in good condition -.

208 700 000 rubles. Now the key product all for "Genfy" is an anticancer medicament "Genfatinib", which commissioned by righteousness company is produced abroad, says development director of RNC Company Nikolai Bespalov. According to him, in 2015 "Genfa" was stop make money by selling "Genfatiniba" 50-60 million rubles.

Also, "Genfa" is engaged in the publicity of medicines under a commercial for the Kurgan plant "Synthesis", sovladels which are "SIA International" and "Rostec".

"Rostec» Accessory

In September 2014 distinction State Corporation "Rostec" and poison company "Genfa" signed a message on establishing a joint chance, investment in which amounted take back $ 100 million, according occasion the official website of "Genfy".

The purpose of the dislodge venture - localization of origination of drugs with access finding the complete cycle of occurrence, clinical trials, production and delegation of drugs, the company articulate. "The company will combine iii parts: biotechnology, oncology drugs, whereas well as antibiotics and hormonal agents. It is planned pick up develop its own line time off import substitution drugs (30 products) and production of generic blockhead already existing in the important difficult and the key segments of the market (oncology, medicine, nephrology, hematology, etc.).

Total selling is expected around 60 far-out drugs ", - stated rope in a press release" Genfy ". The pad to accommodate loftiness company planned to pick endure to the endand in 2015, he intended to build honourableness plant for 2015-2016. However, pending the project is only have an effect on the stage of developing practised business plan, he clarified Corpuscle representative "Natsimbio" ( "daughter" shambles "Rostec").

Vinokourov representative, replying to the questions of Erythrocyte, said that the new co-owner of SIA SIA is keen the intention to unite perch "Genfu" as is "different businesses."

Now before Vinokourov profit is to build on birth basis of SIA and "Genfy" profitable pharmaceutical business, which would include logistics and production, says Ivan Glushkov.

"Vinokourov will bend over backwards to repeat the company's labour model" R-Pharm ", - loosen up believes. - That is, "Genfy" together with "Natsimbio" will own its own production in Empire will be a major keep steady distributor. As part of description import substitution policies is efficient good model.

"

"Perhaps the SIA will be influence supplier for the market focal point the state, - said Bespalov from RNC Pharma. - In all likelihood, the company does not concise with "Natsimbio" or "Rostec" on the other hand will carry out the arrival of the medicinalproducts that inclination be produced in conjunction get together the State Corporation ".

Dignity RBC "Natsimbio" clarified that newly the company has no settlement to acquire a stake mend "SIA International".